Amy S. Espeseth
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 12
- HIV Research and Treatment 12
-
- HIV/AIDS drug development and treatment 9
- Co-authors
- Daria J. HazudaDavid M. MargolisJay A. GroblerAbigail WolfePeter J. FelockMarc WitmerKara A. StillmockNancie M. Archin
- Journals
- Vaccine (6 papers)PLoS ONE (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Virology (4 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Amy S. Espeseth
59 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Virology 2.5k
- Infectious Diseases 2.5k
- Molecular Biology 2.3k
- Immunology 599
- Epidemiology 945
Countries citing papers authored by Amy S. Espeseth
This map shows the geographic impact of Amy S. Espeseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Espeseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Espeseth more than expected).
Fields of papers citing papers by Amy S. Espeseth
This network shows the impact of papers produced by Amy S. Espeseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Espeseth. The network helps show where Amy S. Espeseth may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy S. Espeseth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 12 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 58 | |
| 5 | 2021 | 48 | |
| 6 | 2020 | 111 | |
| 7 | 2019 | 14 | |
| 8 | 2018 | 13 | |
| 9 | 2018 | 17 | |
| 10 | 2016 | 8 | |
| 11 | 2016 | 15 | |
| 12 | 2011 | 36 | |
| 13 | 2011 | 28 | |
| 14 | 2009 | 163 | |
| 15 | 2009 | 279 | |
| 16 | 2009 | 49 | |
| 17 | Genome-Scale RNAi Screen for Host Factors Required for HIV Replication Hit paper breakdown → | 2008 | 615 |
| 18 | 2008 | 17 | |
| 19 | 2007 | 74 | |
| 20 | Evaluation of a Novel Metric for Quality Control in an RNA Interference High Throughput Screening Assay. | 2006 | 3 |
About Amy S. Espeseth
Amy S. Espeseth is a scholar working on Virology, Infectious Diseases, Epidemiology, Microbiology and Molecular Biology, having authored 59 papers that have together received 4.8k indexed citations. Recurring topics across this work include Respiratory viral infections research (13 papers), HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (9 papers), Cytomegalovirus and herpesvirus research (8 papers), Pneumonia and Respiratory Infections (7 papers), Alzheimer's disease research and treatments (7 papers), Herpesvirus Infections and Treatments (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Virology (2.5k citations), Infectious Diseases (2.5k citations), Molecular Biology (2.3k citations), Immunology (599 citations) and Epidemiology (945 citations). Amy S. Espeseth has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Daria J. Hazuda, David M. Margolis, Jay A. Grobler, Abigail Wolfe, Peter J. Felock, Marc Witmer, Kara A. Stillmock, Nancie M. Archin, Adam Gates and William A. Schleif. Their work appears in journals such as Vaccine, PLoS ONE, Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.